Published in Eur J Cardiothorac Surg on June 01, 2004
How effective is microwave ablation for atrial fibrillation during concomitant cardiac surgery? Interact Cardiovasc Thorac Surg (2012) 1.05
Alternative energy sources for surgical treatment of atrial fibrillation in patients undergoing mitral valve surgery: microwave ablation vs cryoablation. J Korean Med Sci (2010) 0.88
Minimally invasive surgical therapies for atrial fibrillation. ISRN Cardiol (2012) 0.87
Can we ablate permanent atrial fibrillation? Heart (2005) 0.79
Surgical treatment of atrial fibrillation: a review. Cardiol Res Pract (2011) 0.78
Strategies in the surgical management of atrial fibrillation. Cardiol Res Pract (2011) 0.78
Effects of endocardial microwave energy ablation. Indian Pacing Electrophysiol J (2005) 0.75
Modern treatment of atrial fibrillation. Korean J Thorac Cardiovasc Surg (2014) 0.75
Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol (2008) 4.50
Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation (2007) 2.58
Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J (2004) 2.11
Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation (2004) 2.03
The vacuum-assisted closure system for the treatment of deep sternal wound infections after cardiac surgery. Ann Thorac Surg (2002) 1.97
Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J (2010) 1.94
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J (2008) 1.83
Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis. Ann Thorac Surg (2007) 1.74
Platelet dysfunction in outpatients with left ventricular assist devices. Ann Thorac Surg (2009) 1.68
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J (2010) 1.63
Heat shock proteins 27, 60, 70, 90alpha, and 20S proteasome in on-pump versus off-pump coronary artery bypass graft patients. Ann Thorac Surg (2008) 1.63
Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation (2005) 1.62
Two dimensional speckle tracking echocardiography: clinical applications. Heart (2010) 1.61
NON-invasive imaging: Two dimensional speckle tracking echocardiography: basic principles. Heart (2010) 1.59
Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation (2004) 1.56
Mitral valve repair with the Colvin-Galloway Future Band. Ann Thorac Surg (2004) 1.56
First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. J Cardiovasc Electrophysiol (2004) 1.53
Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J (2004) 1.52
Neurocognitive deficit following mitral valve surgery. Eur J Cardiothorac Surg (2003) 1.49
Cerebrospinal fluid drainage as a useful treatment option to relieve paraplegia after stent-graft implantation for acute aortic dissection type B. J Thorac Cardiovasc Surg (2002) 1.49
The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb Haemost (2005) 1.46
Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. Eur Heart J (2013) 1.46
A modified and simplified radiofrequency ablation in patients with mitral valve disease. J Thorac Cardiovasc Surg (2005) 1.46
Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg (2003) 1.46
Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg (2004) 1.44
Endovascular stent-graft placement of aneurysms involving the descending aorta originating from chronic type B dissections. Ann Thorac Surg (2007) 1.43
Mechanical aortic valve prostheses in the small aortic root: Top Hat versus standard CarboMedics aortic valve. Ann Thorac Surg (2008) 1.42
Matrix metalloproteases and their tissue inhibitor in cardiac transplantation. Eur J Cardiothorac Surg (2007) 1.41
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med (2004) 1.40
T-wave variability for the prediction of fast ventricular arrhythmias – prospective, observer-blind study. Circ J (2014) 1.40
Quinaprilat during cardioplegic arrest in the rabbit to prevent ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2002) 1.39
Triangular plication of the anterior mitral leaflet: a new operative technique. Ann Thorac Surg (2004) 1.39
Cerebrospinal fluid drainage duration after thoracoabdominal aortic aneurysm repair. Anesthesiology (2003) 1.38
Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial. J Thorac Cardiovasc Surg (2005) 1.29
Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun (2003) 1.28
Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation. Transplantation (2006) 1.24
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma. Br J Haematol (2005) 1.23
Automatic home monitoring of implantable cardioverter defibrillators. Europace (2008) 1.21
Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Shock (2004) 1.20
Combined repair of an aortic arch aneurysm by sequential transposition of the supra-aortic branches and endovascular stent-graft placement. J Thorac Cardiovasc Surg (2003) 1.08
Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg (2007) 1.06
Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng (2005) 1.05
Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart. Eur J Cardiothorac Surg (2004) 1.05
Fleece bound sealing prevents pleural adhesions. Interact Cardiovasc Thorac Surg (2006) 1.04
Lung wedge resection improves outcome in stage I primary spontaneous pneumothorax. Ann Thorac Surg (2004) 1.04
Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. Clin Res Cardiol (2011) 1.04
Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg (2007) 1.03
Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis (2006) 1.02
Intramural left atrial haematoma mimicking cardiac tamponade after catheter ablation of atrial fibrillation. Europace (2009) 1.01
Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg (2009) 0.99
Stent-graft placement in atherosclerotic descending thoracic aortic aneurysms: midterm results. J Endovasc Ther (2004) 0.99
Treatment of symptomatic coral reef aorta by endovascular stent-graft placement. Ann Thorac Surg (2008) 0.99
Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses. J Heart Lung Transplant (2007) 0.98
Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg (2004) 0.97
Complicated infective endocarditis necessitating ICU admission: clinical course and prognosis. Crit Care (2002) 0.97
Successful treatment of an aortoesophageal fistula after emergency endovascular thoracic aortic stent-graft placement. Ann Thorac Surg (2005) 0.96
Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant (2008) 0.96
Surgical treatment of acute type A dissection: is rupture a risk factor? Ann Thorac Surg (2002) 0.96
Normal values for Doppler echocardiographic assessment of heart valve prostheses. J Am Soc Echocardiogr (2003) 0.95
Mid-term results of supraaortic transpositions for extended endovascular repair of aortic arch pathologies. Eur J Cardiothorac Surg (2007) 0.95
Mitral valve endocarditis caused by ulcerative colitis followed by septic embolic occlusion of the superior mesenteric artery. Eur J Echocardiogr (2009) 0.93
Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg (2007) 0.93
Late vascular complications after extracorporeal membrane oxygenation support. Ann Thorac Surg (2006) 0.92
Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer. Clin Cancer Res (2002) 0.92
Images in cardiovascular medicine. Left ventricular echinococcosis with peripheral embolization. Circulation (2002) 0.92
Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol (2002) 0.92
Secondary surgical interventions after endovascular stent-grafting of the thoracic aorta. Eur J Cardiothorac Surg (2004) 0.91
Neurocognitive function in patients with ventricular assist devices: a comparison of pulsatile and continuous blood flow devices. ASAIO J (2006) 0.91
Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun (2003) 0.91
Cognitive deficit after aortic valve replacement. Ann Thorac Surg (2002) 0.91
Two-dimensional speckle-tracking strain echocardiography in long-term heart transplant patients: a study comparing deformation parameters and ejection fraction derived from echocardiography and multislice computed tomography. Eur J Echocardiogr (2011) 0.91
Special considerations on the implantation technique for the MicroMed-DeBakey ventricular assist device axial pump. Ann Thorac Surg (2003) 0.89
Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure. J Thorac Cardiovasc Surg (2009) 0.89
Risk factors of mortality and permanent neurologic injury in patients undergoing ascending aortic and arch repair. J Thorac Cardiovasc Surg (2003) 0.89
Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration. J Am Coll Cardiol (2005) 0.88
Intraoperative iatrogenic type A aortic dissection and perioperative outcome. Interact Cardiovasc Thorac Surg (2005) 0.88
Inflammation and postinfarct remodeling: overexpression of IkappaB prevents ventricular dilation via increasing TIMP levels. Cardiovasc Res (2006) 0.88
Heterogeneity of traumatic injury of the tricuspid valve: a report of four cases. Wien Klin Wochenschr (2008) 0.88
In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery. Antimicrob Agents Chemother (2005) 0.88
Management of central coronary sinus ruptures using the pericardial patch repair technique. Ann Thorac Surg (2006) 0.87
Cystic formation of the foramen ovale mimicking a right atrial myxoma. Ann Thorac Surg (2006) 0.87
Electromagnetic interference by transcutaneous neuromuscular electrical stimulation in patients with bipolar sensing implantable cardioverter defibrillators: a pilot safety study. Pacing Clin Electrophysiol (2003) 0.87
Neurocognitive deficit following coronary artery bypass grafting: a prospective study of surgical patients and nonsurgical controls. Ann Thorac Surg (2004) 0.86
Total endoscopic CABG using robotics on beating heart. Heart Surg Forum (2005) 0.86
Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up. Int J Cardiol (2006) 0.86
Management of open chest and delayed sternal closure with the vacuum assisted closure system: preliminary experience. Interact Cardiovasc Thorac Surg (2008) 0.86
An alternative approach in treating an aortic arch aneurysm with an anatomic variant by supraaortic reconstruction and stent-graft placement. J Vasc Surg (2005) 0.86
HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen. Biol Blood Marrow Transplant (2009) 0.86
Physiology of continuous blood flow in recipients of rotary cardiac assist devices. J Heart Lung Transplant (2005) 0.85
Stem cells and cardiac regeneration. Transpl Int (2007) 0.85
Programmed cell death in idiopathic dilated cardiomyopathy is mediated by suppression of the apoptosis inhibitor Apollon. Ann Thorac Surg (2008) 0.85
Expression of surface protein receptors in lung cancer. Anticancer Res (2003) 0.85